SNCA and Parkinson disease: Similar observations were made in an in vivo PD mouse model in which transplantation of healthy midbrain astrocytes into the midbrain of the α-synuclein expressing PD mice attenuated α-synuclein pathology and dopaminergic toxicity [57].